Allergan posted a 12.9 percent sales increase to $1,528.4 million...

Allergan posted a 12.9 percent sales increase to $1,528.4 million for the quarter ended Sept. 30, driven by both its pharmaceutical and medical device businesses. On a constant currency basis, the increase in total product net sales was of 14.0 percent compared with the third quarter of 2012. Total specialty ...

You need to register to continue reading this article

Already subscribe to Eyewear intelligence? Sign in here

Register to continue reading

By registering today you will have access to:

  • 3 industry news articles per month

For full access and to receive in-depth news, analysis and more, become a member today

For more content and resources become a member? View our membership packages.